Urol. praxi, 2016; 17(1): 14-16 | DOI: 10.36290/uro.2016.004

Retroperitoneal fibrosis

MUDr.Ján ©vihra, MUDr.Vladimír ©tudent jr., doc.MUDr.Vladimír ©tudent, Ph.D.
Urologická klinika FN Olomouc

Retroperitoneal fibrosis is a rare chronic inflammatory disease. Urologist have major role in it's diagnosis and treatment because

of typical symptoms of obstruction of ureters. Around 1/3 of cases follows various diseases. The rest of cases has idiopathic ethiology

and is called Ormond's disease. The biggest contribution to diagnosis has CT scan and histological examination of bioptic



material: Because of rarity of disease there are not enough data on effects or assessment of therapy. There is constant search of

new drugs and their combination. New invasive procedures like robotic-assisted surgery and autotransplantation of kidney also

appear. The combination of surgical therapy and pharmacological therapy seems suitable.

Keywords: retroperitoneal fibrosis, Ormond΄s disease, treatment

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©vihra J, ©tudent V, ©tudent V. Retroperitoneal fibrosis. Urol. praxi. 2016;17(1):14-16. doi: 10.36290/uro.2016.004.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol. 2008; 191(2): 423. Go to original source... Go to PubMed...
    2. Uibu T, Oksa P, Auvinen A, Honkanen E, Metsärinne K, Saha H, Uitti J, Roto P. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004; 363(9419): 1422. Go to original source... Go to PubMed...
    3. van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009; 88(4): 193. Go to original source... Go to PubMed...
    4. Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, Savi M, Buzio C, Neri TM. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 2006; 55(1): 126. Go to original source... Go to PubMed...
    5. Brito-Zerón P, Ramos-Casals M, Bosch X, Stone JH. The clinical spectrum of IgG4-related disease. Autoimmun. Rev. 2014; 13: 1203-1210. Go to original source... Go to PubMed...
    6. Couderc M, Mathieu S, Dubost JJ, Soubrier M. Retroperitoneal fibrosis during etanercept therapy for rheumatoid arthritis. J. Rheumatol. 2012; 40: 1931-1933. Go to original source...
    7. Průcha M, Kolombo I, ©tádler P. Ormond's Disease - IgG4-related Disease. Prague Medical Report. 2015; 116(3): 181-192. Go to original source... Go to PubMed...
    8. Cartery C, Astudillo L, Deelchand A, Moskovitch G, Sailler L, Bossavy JP, Arlet P. Abdominal infectious aortitis caused by Streptococcus pneumoniae: a case report and literature review. Ann. Vasc. Surg. 2011; 25:, 266.e9-266.e16. Go to original source... Go to PubMed...
    9. Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet 2006; 367: 241-251. Go to original source... Go to PubMed...
    10. Scott J, Foster R, Moore A. Retroperitoneal fibrosis and nonmalignant ileal carcinoid. J Urol 1987; 138: 1435. Go to original source... Go to PubMed...
    11. Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 1990; 114: 383-387.
    12. Vaglio A, Corradi D, Manenti L, et al. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003; 114: 44-62. Go to original source... Go to PubMed...
    13. Aziz F, Conjeevaram S, Phan T. Retroperitoneal fibrosis: a rare cause of both ureteral and small bowel obstruction. World J Gastroenterol 2006; 12: 7061-7063. Go to original source... Go to PubMed...
    14. Dejaco C, Ferenci P, Schober E, Kaserer K, Fugger R, Novacek G, et al. Stenosis of the common bile duct due to Ormond's disease: case report and review of the literature. J Hepatol 1999; 31: 156-159. Go to original source... Go to PubMed...
    15. Barrison IG, Walker JG, Jones C, Snell ME. Idiopathic retroperitoneal fibrosis-is serum alkaline phosphatase a marker of disease activity?. Postgrad Med J. 1988; 64(749): 239-241. Go to original source... Go to PubMed...
    16. George V, Tammisetti V, Surabhi V, Shanbhogue A. Chronic fibrosing conditions in abdominal imaging. Radiographics. 2013; 33(4): 1053-1080. Go to original source... Go to PubMed...
    17. Dash R, Liu K, Sheafor D, Dodd L. Fine-needle aspiration findings in idiopathic retroperitoneal fibrosis. Diagn Cytopathol. 1999; 21(1): 22-26. Go to original source... Go to PubMed...
    18. Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery. 1977; 81(3): 250-257. Go to PubMed...
    19. Van Bommel E. Retroperitoneal fibrosis. Neth J Med. 2002; 60(6): 231-242.
    20. Harreby M, Bilde T, Helin P, Meyhoff H, Vinterberg H, Nielsen V. Retroperitoneal fibrosis treated with methylprednisolon pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol. 1994; 28(3): 237-242. Go to original source...
    21. Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011; 378(9788): 338-346. Go to original source... Go to PubMed...
    22. Moroni G, Gallelli B, Banfi G, Sandri S, Messa P, Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant. 2006; 21(9): 2485-2490. Epub 2006 May 15. Go to original source... Go to PubMed...
    23. Adler S, Lodermeyer S, Gaa J, Heemann U. Successful mycophenolate mofetil therapy in nine patients with idiopathic retroperitoneal fibrosis. Rheumatology (Oxford). 2008; 47(10): 1535-1538. Go to original source... Go to PubMed...
    24. Marzano A, Trapani A, Leone N, Actis G, Rizzetto M. Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis. 2001; 60(4): 427-428. Go to original source... Go to PubMed...
    25. Kaipiainen-Seppanen O, Jantunen E, Kuusisto J, Marin S. Retroperitoneal fibrosis with antineutrophil cytoplasmic antibodies. J Rheumatol. 1996; 23(4): 779-781. Go to PubMed...
    26. McDougal WS, MacDonell RC. Treatment of idiopathic retroperitoneal fibrosis by immunosuppression. J Urol. 1991; 145(1): 112-114. Go to original source... Go to PubMed...
    27. Barnhill D, Hoskins W, Burke T, et al. The treatment of retroperitoneal fibromatosis with medroxyprogesterone acetate. Obstet Gynecol. 1987; 70(3 Pt 2): 502-504. Go to PubMed...
    28. Comini Andrada E, Hoschoian JC, Anton E, Lanari A. Growth inhibition of fibroblasts by progesterone and medroxyprogesterone in vitro. Int Arch Allergy Appl Immunol. 1985; 76(2): 97-100. Go to original source... Go to PubMed...
    29. Monev S. Idiopathic retroperitoneal fibrosis: prompt diagnosis preserves organ function. Cleve Clin J Med. 2002; 69(2): 160-166. Go to original source... Go to PubMed...
    30. Srinivasan A, Richstone L, Permpongkosol S, Kavoussi L. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. J Urol.2008; 179(5): 1875-1878. Go to original source... Go to PubMed...
    31. Kavoussi LR, Clayman RV, Brunt LM, Soper NJ. Laparoscopic ureterolysis. J Urol. 1992 Feb. 147(2): 426-429. Go to original source... Go to PubMed...
    32. Matsuda T, Arai Y, Muguruma K, et al. Laparoscopic ureterolysis for idiopathic retroperitoneal fibrosis. Eur Urol. 1994; 26(4): 286-290. Go to original source... Go to PubMed...
    33. Fugita OE, Jarrett TW, Kavoussi P, Kavoussi LR. Laparoscopic treatment of retroperitoneal fibrosis. J Endourol. 2002; 16(8): 571-574. Go to original source... Go to PubMed...
    34. Styn NR, Frauman S, Faerber GJ, Wolf JS Jr. University of Michigan surgical experience with ureterolysis for retroperitoneal fibrosis: a comparison of laparoscopic and open surgical approaches. Urology. 2011; 77(2): 339-343. Go to original source... Go to PubMed...
    35. Slavis SA, Wilson RW, Jones RJ, Swift C. Long-term results of permanent indwelling wallstents for benign mid-ureteral strictures. J Endourol. 2000; 14(7): 577-581. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.